The market climbed 2%. One position dropped 12% in three days.

The week at a glance

ERNA dropped 12.9% in three days. That's the number that defines this week, and I'd rather say it up front than bury it in a table. The week ending July 3rd was the kind of week where the market ripped — SPY +2.17% — and our open book sat out the party. We finished -0.37% against that, a -2.54% alpha week. That stings. There's no frame that makes it not sting. Here's what the full picture looks like right now: | Ticker | Engine | Entry Date | Entry Price | Week P&L | Status | |--------|-----------------|------------|-------------|----------|--------| | PIII | Relative Strength | Jun 15 | $12.81 | -11.24% | Open | | CWAN | Breakout | Jun 22 | $24.52 | +0.16% | Open | | CUE | Relative Strength | Jun 25 | $26.43 | +6.92% | Open | | ENVA | Breakout | Jun 30 | $240.16 | -2.07% | Open | | ERNA | Relative Strength | Jul 1 | $7.20 | -12.92% | Open | | CUE | Relative Strength | Jul 2 | $29.49 | -4.17% | Open | Six open positions. Zero closed this week. That's actually part of the story — we're carrying drawdown that hasn't resolved yet, which is a different thing from drawdown that has resolved badly. The math is still the math: this week hurt. Zoom out one level: cumulative alpha-to-date sits at +1.17%. The system has been running 26 days. We've given back some of last week's cushion, but not all of it. That's context — not comfort.

Trades we closed this week

No trades closed this week, so there's no clean per-trade postmortem to run. What there is: an honest look at what's happening inside each position. PIII is on day 19 and down 11.2%. It's the longest-running wound in the book right now. The Relative Strength Engine flagged it when the setup was valid — the problem is the stock hasn't followed through. If it doesn't start recovering, we cut it. We're watching that line closely. ERNA is the freshest pain. Opened July 1st, already down 12.9% by end of week. Three days. That kind of move makes you second-guess an entry, and there's no point pretending otherwise. The Relative Strength Engine saw something real — small-cap biotech signals can gap and run hard. They can also gap the other way. This one went the other way. The two CUE positions deserve an explanation. Yes, the same ticker appears twice — opened June 25th at $26.43 and again July 2nd at $29.49, on two separate signals. The first is up 6.9%. The second is down 4.2%. We skipped two signals entirely this week on watchlist days, so this wasn't a case of pulling the trigger on everything in sight. Both CUE entries came through the Relative Strength Engine on different days, different conditions, different reads. CWAN is barely above water at +0.16%. ENVA opened June 30th and is sitting at -2.07% through week's end. Neither is a crisis — but neither is a win yet, either. The win rate on closed trades still holds at 75% (3 of 4 over the life of the experiment). That number still looks clean. But it's a small sample, and right now the open book is doing its best to test our patience.

What we tuned this week

We didn't touch the system this week — no parameter tuning, no engine adjustments. What we did do was hold discipline on two watchlist days, sitting out signals that didn't meet our full criteria. In a week where adding exposure would have added pain, that was probably the right call. We can't know for certain, but we're not second-guessing it. Heading into next week, we're carrying six open positions — two of them, PIII and ERNA, deep enough in drawdown to demand attention. The system's stop logic governs exits. We're not going to manually override because we have feelings about a name. That's the whole point of running this systematically. If new signals come in next week, we'll evaluate them on their own merits. The current book's pain doesn't disqualify a clean new setup — those are separate questions.

What we're cautious about next week

The honest risk heading into next week: PIII and ERNA don't recover, we take two more stop-outs, and a week that already underperformed gets worse. That scenario pushes cumulative alpha negative. We'd report it straight if it happens. Broader market context matters here too. SPY ran 2.17% this week. If that was a short-covering rally or a holiday-week drift rather than a real momentum shift, the tape could look very different in the first full week of July. Our positions skew toward smaller names — they don't track SPY cleanly in either direction, up or down. Position concentration is also worth naming. Two CUE entries plus four other open names — six positions drawing from the same risk budget. Nothing violates our rules, but a bad tape day touches all of them at once. This is the part of running a systematic approach where you either trust the rules or you don't. We do. But we're not going to pretend the next few days are low-stakes.

Looking ahead to Monday

Twenty-six days in. Cumulative alpha still positive — barely. A 75% win rate on closed trades, a book full of open ones, and a week where the market climbed and we didn't climb with it. That's the honest summary. Next week is the first full trading week of July. Earnings season starts picking up. Liquidity returns after the holiday. Any of the six open positions could resolve — in either direction — by Thursday. PIII and ERNA are the ones we'll be watching most closely. If they stabilize, this week looks like noise. If they don't, we'll say so.